Analyzing CONMED Corporation (NASDAQ:CNMD) and The Competition

CONMED Corporation (NASDAQ: CNMD) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its peers? We will compare CONMED Corporation to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, dividends, valuation, earnings and risk.

Analyst Ratings

This is a summary of recent recommendations and price targets for CONMED Corporation and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED Corporation 0 3 1 0 2.25
CONMED Corporation Competitors 180 1144 2503 89 2.64

CONMED Corporation currently has a consensus price target of $49.33, indicating a potential downside of 6.39%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 7.20%. Given CONMED Corporation’s peers stronger consensus rating and higher probable upside, analysts clearly believe CONMED Corporation has less favorable growth aspects than its peers.

Insider and Institutional Ownership

98.4% of CONMED Corporation shares are owned by institutional investors. Comparatively, 66.2% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 2.6% of CONMED Corporation shares are owned by company insiders. Comparatively, 11.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


CONMED Corporation pays an annual dividend of $0.80 per share and has a dividend yield of 1.5%. CONMED Corporation pays out 142.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Medical Equipment, Supplies & Distribution” companies pay a dividend yield of 0.8% and pay out 36.9% of their earnings in the form of a dividend.

Valuation and Earnings

This table compares CONMED Corporation and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
CONMED Corporation $772.61 million $123.91 million 94.11
CONMED Corporation Competitors $827.23 million $159.50 million 41.26

CONMED Corporation’s peers have higher revenue and earnings than CONMED Corporation. CONMED Corporation is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.


This table compares CONMED Corporation and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CONMED Corporation 2.02% 8.38% 3.66%
CONMED Corporation Competitors -126.58% -36.58% -10.02%

Risk & Volatility

CONMED Corporation has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, CONMED Corporation’s peers have a beta of 1.06, indicating that their average share price is 6% more volatile than the S&P 500.


CONMED Corporation peers beat CONMED Corporation on 10 of the 15 factors compared.

About CONMED Corporation

CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company’s product lines consist of orthopedic surgery, general surgery and surgical visualization. As of December 31, 2016, the Company’s products are distributed domestically directly to over 6,000 hospitals, surgery centers and other healthcare institutions, as well as through medical specialty distributors. The Company’s orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. These products are marketed under a range of brands, including Hall, CONMED Linvatec, Concept and Shutt.

Receive News & Ratings for CONMED Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONMED Corporation and related companies with's FREE daily email newsletter.

Leave a Reply